SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 18th, 2016 • Bio Blast Pharma Ltd. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March 16, 2016, between BioBlast Pharma Ltd., an Israeli corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
CO-PLACEMENT AGENCY AGREEMENTCo-Placement Agency Agreement • March 18th, 2016 • Bio Blast Pharma Ltd. • Pharmaceutical preparations • New York
ORDINARY SHARE PURCHASE WARRANT bio blast pharma ltd.Ordinary Share Purchase Agreement • March 18th, 2016 • Bio Blast Pharma Ltd. • Pharmaceutical preparations
THIS ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after September ___, 2016 (the “Initial Exercise Date”) and on or prior to the close of business on September ___, 2021 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Bio Blast Pharma Ltd., an Israeli corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Ordinary Shares, NIS 0.01 par value (the “Ordinary Share(s)”). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
